MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 527408 | Name: BTA-9881
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BTA-9881, also known as AZD-9639 and MEDI-564, is a viral fusion protein inhibitor potentially for the treatment of respiratory syncytial virus infection.

Chemical Structure

BTA-9881
BTA-9881
CAS#1646857-24-0

Theoretical Analysis

MedKoo Cat#: 527408

Name: BTA-9881

CAS#: 1646857-24-0

Chemical Formula: C21H15ClN4O2

Exact Mass: 390.0884

Molecular Weight: 390.83

Elemental Analysis: C, 64.54; H, 3.87; Cl, 9.07; N, 14.34; O, 8.19

Price and Availability

Size Price Availability Quantity
1mg USD 90.00 Ready to ship
5mg USD 450.00 Ready to ship
10mg USD 750.00 Ready to ship
25mg USD 1,650.00 Ready to ship
50mg USD 2,650.00 Ready to ship
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
BTA-9881; BTA 9881; BTA9881; AZD-9639; AZD9639;AZD 9639; MEDI-564; MEDI564; MEDI 564;
IUPAC/Chemical Name
(S)-9b-(4-chlorophenyl)-1-nicotinoyl-1,2,3,9b-tetrahydro-5H-imidazo[1',2':1,2]pyrrolo[3,4-c]pyridin-5-one
InChi Key
QZSZPSDRJPPZDZ-OAQYLSRUSA-N
InChi Code
InChI=1S/C21H15ClN4O2/c22-16-5-3-15(4-6-16)21-18-13-24-9-7-17(18)20(28)26(21)11-10-25(21)19(27)14-2-1-8-23-12-14/h1-9,12-13H,10-11H2/t21-/m1/s1
SMILES Code
O=C1N2[C@@](C3=C1C=CN=C3)(C4=CC=C(Cl)C=C4)N(C(C5=CC=CN=C5)=O)CC2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Biological target:
BTA-9881, also known as AZD-9639 and MEDI-564, is a viral fusion protein inhibitor potentially for the treatment of respiratory syncytial virus infection.
In vitro activity:
TBD
In vivo activity:
TBD
Solvent mg/mL mM
Solubility
DMSO 0.0 0.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 390.83 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Bonfanti JF, Roymans D. Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection. Curr Opin Drug Discov Devel. 2009 Jul;12(4):479-87. Review. PubMed PMID: 19562644.